◂ Announcements

Apr 8, 2020ACQUISITIONDenmark

SARSTEDT acquires 80% stake in Timedico

SARSTEDT AG & Co. KG acquired 80% of shares in Timedico A/S, a Danish developer of the Tempus600 blood sample transport system, with a right to acquire the remaining 20%. The deal was announced on 8 April 2020.

Status

Completed

Productsblood sample transport system Tempus600blood collection system S-Monovette

CompaniesSARSTEDT AG & Co. KG acquirer Timedico A/S target

Sectors#Medical Devices

“SARSTEDT AG & Co. KG adquiriu 80% das ações da Timedico e garantiu o direito de adquirir 20% adicionais em um futuro próximo.”newslab.com.br

1 source
newslab.com.brSARSTEDT se tornará acionista majoritária da Timedico | NewslabLuciene AlmeidaMay 5, 2020

Summarized from public sources; check the original articles before acting on it.

Similar announcements

Nov 6, 2026ACQUISITIONUnited States$9.90B
Danaher to acquire Masimo for $9.9 billion
Danaher acquirer Masimo target mdtvnow.com
Nov 5, 2026ACQUISITIONUnited States
Curewell Capital to acquire majority stake in ECA Medical
Curewell Capital acquirer ECA Medical target businesswire.com
Nov 5, 2026ACQUISITIONUnited States$538.0M
ZOLL Medical to acquire Itamar Medical for $538M
Asahi Kasei investor ZOLL Medical Corporation acquirer forpressrelease.com
Nov 4, 2026ACQUISITIONPlano, Texas, United States$2.25M
OSTEONIC acquires controlling stake in FoxEyes for 3 billion won
OSTEONIC FoxEyes target en.edaily.co.kr
Nov 3, 2026ACQUISITIONDeerfield, Illinois, United States
Vantive to divest majority of hemodialysis assets to Rockwell Medical
Vantive Rockwell Medical acquirer prnewswire.com
Nov 3, 2026ACQUISITIONMedolla, Italy, Italy$125.0M
Rockwell Medical to acquire Vantive's hemodialysis business for $400-450M annual revenue
Rockwell Medical acquirer Vantive target sec.gov nasdaq.com securities.io

Loading…